Alkaloid AD Skopje (XMAE:ALK) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XMAE:ALK Alkaloid AD Skopje XMAE:ALK
100 GF Score
Price MKD23,499.00
GF Value MKD27,451.69
Valuation Modestly Undervalued
View Full Analysis

What is Alkaloid AD Skopje Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Alkaloid AD Skopje is: High Risk: High uncertainty with risk-return tradeoff.

Alkaloid AD Skopje  (XMAE:ALK) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Alkaloid AD Skopje Risk Assessment Related Terms

XMAE:ALK vs ZTS, UTHR, VTRS: Risk Assessment Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alkaloid AD Skopje's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alkaloid AD Skopje Risk Assessment vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkaloid AD Skopje's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Alkaloid AD Skopje's Risk Assessment falls into.


XMAE:ALK
100GF Score
Alkaloid AD Skopje XMAE:ALK
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Alkaloid AD Skopje (XMAE:ALK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkaloid AD Skopje stock appears to be undervalued. The current stock price of MKD23,499.00 is trading 14.4% below its estimated GF Value™ of MKD27,451.69. GuruFocus considers Alkaloid AD Skopje to be Modestly Undervalued.

Key valuation signals for XMAE:ALK:

  • Risk Assessment:
  • GF Value™: MKD27,451.69 vs. price of MKD23,499.00 (14.4% below fair value)
  • GF Score™: 100/100

No single metric tells the full story. See the XMAE:ALK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkaloid AD Skopje Business Description

Address Boulevard Aleksandar, Makedonski 12, Skopje, MKD, 1000
Alkaloid AD Skopje is engaged in producing and selling pharmaceutical, chemical and cosmetic products, as well as goods from the herbal origin. Its segments are Pharmaceuticals, Chemicals, Cosmetics and Botanicals. It derives maximum revenue from Pharmaceuticals products segment.
100GF Score

Get the complete analysis for XMAE:ALK

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MKD23,499.00
Price
MKD27,451.69
GF Value